Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 3
1966 6
1967 2
1968 1
1969 9
1970 1
1971 14
1972 3
1973 7
1974 4
1975 2
1976 3
1977 4
1978 6
1979 1
1980 6
1981 5
1982 6
1983 5
1984 11
1985 6
1986 7
1987 5
1988 5
1989 14
1990 11
1991 16
1992 18
1993 12
1994 17
1995 12
1996 11
1997 18
1998 16
1999 19
2000 22
2001 24
2002 20
2003 32
2004 49
2005 46
2006 51
2007 59
2008 58
2009 68
2010 59
2011 74
2012 91
2013 73
2014 85
2015 91
2016 92
2017 75
2018 111
2019 129
2020 155
2021 191
2022 197
2023 174
2024 63

Text availability

Article attribute

Article type

Publication date

Search Results

2,065 results

Results by year

Filters applied: . Clear all
Page 1
Eosinophilic Lung Diseases.
Cottin V. Cottin V. Immunol Allergy Clin North Am. 2023 May;43(2):289-322. doi: 10.1016/j.iac.2023.01.002. Immunol Allergy Clin North Am. 2023. PMID: 37055090 Review.
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.
Dellon ES, Rothenberg ME, Collins MH, Hirano I, Chehade M, Bredenoord AJ, Lucendo AJ, Spergel JM, Aceves S, Sun X, Kosloski MP, Kamal MA, Hamilton JD, Beazley B, McCann E, Patel K, Mannent LP, Laws E, Akinlade B, Amin N, Lim WK, Wipperman MF, Ruddy M, Patel N, Weinreich DR, Yancopoulos GD, Shumel B, Maloney J, Giannelou A, Shabbir A. Dellon ES, et al. N Engl J Med. 2022 Dec 22;387(25):2317-2330. doi: 10.1056/NEJMoa2205982. N Engl J Med. 2022. PMID: 36546624 Clinical Trial.
Biologics in eosinophilic gastrointestinal diseases.
Dellon ES, Spergel JM. Dellon ES, et al. Ann Allergy Asthma Immunol. 2023 Jan;130(1):21-27. doi: 10.1016/j.anai.2022.06.015. Epub 2022 Jun 20. Ann Allergy Asthma Immunol. 2023. PMID: 35738437 Free PMC article. Review.
Eosinophilic Gastritis/Gastroenteritis.
Chen PH, Anderson L, Zhang K, Weiss GA. Chen PH, et al. Curr Gastroenterol Rep. 2021 Jul 30;23(8):13. doi: 10.1007/s11894-021-00809-2. Curr Gastroenterol Rep. 2021. PMID: 34331146 Review.
Tezepelumab: First Approval.
Hoy SM. Hoy SM. Drugs. 2022 Mar;82(4):461-468. doi: 10.1007/s40265-022-01679-2. Drugs. 2022. PMID: 35184265 Review.
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
Valent P, Klion AD, Roufosse F, Simon D, Metzgeroth G, Leiferman KM, Schwaab J, Butterfield JH, Sperr WR, Sotlar K, Vandenberghe P, Hoermann G, Haferlach T, Moriggl R, George TI, Akin C, Bochner BS, Gotlib J, Reiter A, Horny HP, Arock M, Simon HU, Gleich GJ. Valent P, et al. Allergy. 2023 Jan;78(1):47-59. doi: 10.1111/all.15544. Epub 2022 Oct 19. Allergy. 2023. PMID: 36207764 Free PMC article. Review.
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
Wechsler ME, Klion AD, Paggiaro P, Nair P, Staumont-Salle D, Radwan A, Johnson RR, Kapoor U, Khokhar FA, Daizadeh N, Chen Z, Laws E, Ortiz B, Jacob-Nara JA, Mannent LP, Rowe PJ, Deniz Y. Wechsler ME, et al. J Allergy Clin Immunol Pract. 2022 Oct;10(10):2695-2709. doi: 10.1016/j.jaip.2022.05.019. Epub 2022 May 28. J Allergy Clin Immunol Pract. 2022. PMID: 35636689 Free article.
Emerging therapies for eosinophilic esophagitis.
Meek PD, Hemstreet B. Meek PD, et al. Pharmacotherapy. 2023 Apr;43(4):338-348. doi: 10.1002/phar.2783. Epub 2023 Mar 11. Pharmacotherapy. 2023. PMID: 36840634 Review.
2,065 results